Study of malaria parasites reveals new parasitic statesNovember 29, 2007A team led by scientists at MIT and Harvard University and supported in part by the National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health, collected blood samples from 43 P. falciparum-infected malaria patients in Senegal who were suffering from a range of malaria symptoms. The scientists isolated the parasites' genomic information and determined which of the nearly 6,000 P. falciparum genes were switched on or off during infection, revealing distinct groups of parasites with characteristic sets of active and inactive genes. By comparing this information about P. falciparum with gene activation patterns in a similar but better-understood organism-baker's yeast-the scientists described three biological classes of malaria parasites, each with a different metabolic state. One state is well known from laboratory studies, but the other two have never been observed before. One newly described state appears to reflect starving parasites, while the other suggests parasites under extreme environmental stress. Remarkably, say the scientists, the latter group correlated with specific patient symptoms, including high fevers and elevated levels of inflammatory markers in their blood. These findings suggest that the state of the parasite may correlate with a malaria patient's symptoms, which can range from mild, flu-like illness to coma and even death. If further research confirms such direct relationships, this could open the door to the development of new malaria treatments that ameliorate disease symptoms by targeting the parasite's behavior. NIH/National Institute of Allergy and Infectious Diseases |
|||||||||||||||||||||
| Related Malaria Current Events and Malaria News Articles Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. On the Trail of a Vaccine for Lyme Disease: Yale Researchers Target Tick Saliva A protein found in the saliva of ticks helps protect mice from developing Lyme disease, Yale researchers have discovered. The findings, published in the November 19 issue of Cell Host & Microbe, may spur development of a new vaccine against infection from Lyme disease, which is spread through tick bites. Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease. Small nanoparticles bring big improvement to medical imaging If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging. Prioritizing low-cost, simple health measures would save 2.5 million child lives a year Almost a third of the children under age five who die each year could be saved if governments rebalance health spending to ensure low-cost, simple interventions such as safe water and hygiene, bed nets and basic maternal and newborn care, leading aid agency World Vision said today. Currently, 8.8 million children a year die before age five, most of preventable causes. Drug industry, nonprofits join forces to fight world's neglected diseases Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. DNA barcodes: Creative new uses span health, fraud, smuggling, history, more The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others. PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa. More Malaria Current Events and Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||